(S1 (S (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (NN IL-6) (NN release)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NN NF-kappaB) (NN activity))) (SBAR (IN while) (S (NP (NN CXCL8) (NN release)) (ADVP (RBR more) (RB closely)) (VP (VBD correlated) (PP (IN with) (NP (NN AP-1) (NN activity))))))))))))) (. .)))
(S1 (S (S (NP (NP (NN Treatment)) (PP (IN of) (NP (NN Jurkat) (NNS T-cells))) (PP (IN with) (NP (NN PMA)))) (VP (VBD was) (ADJP (ADJP (RBR more) (JJ potent) (PP (IN than) (NP (NN HK)))) (ADJP (FW E.) (FW coli))) (PP (IN at) (S (VP (VBG elevating) (NP (DT the) (NN CXCL8) (NNS levels))))))) (. .)))
(S1 (S (S (NP (NN PMA)) (VP (VP (VBD induced) (NP (NN AP-1) (NN activation))) (CC and) (VP (VBD down-regulated) (NP (NN NF-kappaB)) (SBAR (IN while) (S (NP (NN HK)) (ADVP (FW E.) (FW coli)) (VP (VBD up-regulated) (NP (NN NF-kappaB)) (PP (IN without) (S (VP (VBG affecting) (NP (NN AP-1) (NN activity))))))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT the) (JJ temporal) (NN induction) (NN pattern)) (PP (IN of) (NP (NN AP-1)))) (VP (VBD correlated) (PP (TO to) (NP (NP (DT the) (NN release)) (PP (IN of) (NP (NN CXCL8))))) (SBAR (IN while) (S (NP (NN IL-6)) (VP (VBD followed) (NP (DT the) (NN NF-kappaB) (NN activity))))))) (. .)))
(S1 (S (S (ADVP (RB Likewise)) (, ,) (NP (NN blocking) (NN NF-kappaB) (NN activation)) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (JJ complete) (NN inhibition)) (PP (IN of) (NP (NN IL-6))))) (SBAR (IN while) (S (NP (DT the) (NN CXCL8) (NNS levels)) (VP (VBD remained) (ADJP (JJ elevated)) (SBAR (IN as) (S (VP (VBN shown) (PP (CC both) (IN at) (NP (DT the) (NN protein) (CC and) (NN mRNA) (NN level))))))))))) (. .)))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (DT the) (NN CXCL8) (NN release)) (VP (VBD was) (VP (VBN down-regulated) (PP (IN by) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN JNK) (NN activity)))))))) (. .)))
(S1 (S (S (NP (DT The) (JJ present) (NN study)) (VP (VBZ indicates) (SBAR (IN that) (S (PP (IN in) (NP (NN Jurkat) (NNS T-cells))) (, ,) (NP (NN IL-6)) (VP (VBZ is) (VP (VBN regulated) (PP (IN through) (NP (NN NF-kappaB))) (SBAR (IN while) (S (NP (NN CXCL8) (NN regulation)) (VP (VBZ is) (UCP (ADJP (JJ independent) (PP (IN of) (NP (NN NF-kappaB)))) (CC and) (VP (ADVP (RB closely)) (VBN associated) (PP (IN with) (NP (NN AP-1) (NN activation)))))))))))))) (. .)))
